My Life On GLP1

74% of MASH patients achieved disease resolution with tirzepatide in new trials. We explore how Mounjaro and Zepbound reverse liver scarring, reduce fibrosis, and offer hope for the 30% of Americans w...

29 Loka 20256min

12% of Americans have tried GLP-1 medications—but what are they actually experiencing? We break down the stats: 40% get nausea, 73% have GI issues, why women lose hair 14x more than men, and discontin...

28 Loka 20257min

A hilarious treadmill disaster leads to profound insights about compassion. Discover how Zepbound transformed not just weight but worldview—from judging others to understanding biology's role in obesi...

28 Loka 20256min

Could your weight loss medication cure migraines? New research shows GLP-1 drugs reduce migraine days by 50%. We explore how Ozempic, Wegovy, Mounjaro affect brain pressure, CGRP pathways & pain circu...

27 Loka 20256min

Discover why age dramatically impacts GLP-1 medication results. From teens losing 16% BMI to seniors battling Medicare gaps, we break down Ozempic, Wegovy, Mounjaro & Zepbound effectiveness across gen...

27 Loka 20256min

My Life on GLP-1 is returning for Series 13 next week! Get the straight facts on weight loss meds, GLP-1 breakthroughs, side effects, success stories, and helpful tips. Whether you're on Ozempic, Moun...

26 Loka 20251min

What if your weight loss medication was actually saving your heart? Discover how Ozempic, Wegovy, Mounjaro, and Zepbound reduce heart attack and stroke risk by up to 26% even before you lose weight. W...

2 Loka 20256min

Ever noticed your mind feels sharper on weight loss meds? You're not imagining it. We're diving into the unexpected cognitive benefits of GLP-1 medications like Zepbound and Mounjaro—from reduced brai...

2 Loka 20257min